Salto Partners

  • Home
  • About
  • Services
    • Strategy
    • Execution
    • Compliance
  • Verticals
    • Life Sciences
    • Genomics
    • Private Equity
  • Insights
    • ISO 13485
    • IVDR
    • Perspectives
      • National Genome Programs
      • Pharmacogenomics at Scale
      • Long-Read Sequencing
      • AI in Clinical Genomics
  • News
  • Contact

Post-Market Surveillance and Vigilance

The IVDR expects manufacturers to actively monitor their devices once they are on the market, learn from real-world use, and act quickly when something goes wrong.

The post-market surveillance system

  • PMS plan: how data will be collected and analyzed, including complaints, trends, literature, similar devices and user feedback
  • Post-market performance follow-up (PMPF): proactive collection of performance data to confirm and update the performance evaluation
  • PMS report (Class A and B): summary of results and actions, updated when necessary
  • Periodic safety update report, PSUR (Class C and D): updated at least annually, with Class D PSURs reviewed by the notified body

Vigilance

Manufacturers must report serious incidents and field safety corrective actions to the competent authorities. Reporting deadlines are short:

SituationReport no later than
Serious public health threat2 days after becoming aware
Death or unanticipated serious deterioration in health10 days after becoming aware
Other serious incidents15 days after becoming aware

Manufacturers must also report statistically significant increases in the frequency or severity of non-serious incidents or expected erroneous results (trend reporting), and issue field safety notices when corrective action is needed.

Making it work in practice

  • Connect PMS directly to complaint handling, CAPA and risk management
  • Make sure distributors report complaints quickly and completely
  • Define clear criteria for when an erroneous result becomes a reportable incident
  • Use PMS data to update the performance evaluation and labeling

IVDR guide
Overview  ·  Scope and Key Definitions  ·  Risk Classification  ·  Conformity Assessment and Notified Bodies  ·  Performance Evaluation  ·  Technical Documentation  ·  Post-Market Surveillance and Vigilance  ·  Economic Operators, UDI and EUDAMED  ·  Transition Deadlines and Reform

Need help? Salto Partners guides diagnostics, genomics and medical device companies through ISO 13485 and IVDR. Send us an email and we will set up a conversation.

For general information only; not legal or regulatory advice. Regulations and deadlines change, so confirm current requirements with your notified body or regulatory counsel. Last updated October 2026.

© 2026 Salto Partners Inc. · Strategy. Execution. Compliance.